Abstract

Research Article

Stem cells in patients with heart failure experience

Benetti Federico* and Natalia Scialacomo

Published: 20 April, 2018 | Volume 2 - Issue 1 | Pages: 004-014

Between 2003 and 2011, 17 patients with heart failure were treated with stem cells as part of our Foundation’s Regenerative Medicine program. In several centers and countries 4 with ischemic cardiomyopathy of which 3 were surgically implanted with autologous bone marrow stem cells (ABMSC) plus bypass surgery. One patient was treated with hyperbaric medicine plus bypass surgery. Patients with idiopathic cardiomyopathy were implanted surgically with 2 different types of stem cells. Ten patients were implanted with stem cells derived from human fetuses (HFDSCs) and three patients with autologous bone marrow stem cells (ABMSC). The ejection fractions of the coronary artery bypass graft off pump OPCAB (control group) versus coronary artery bypass group off pump OPCAB plus stem cell transplantation were as followsin the entire serie: preoperative, 30.7% +/- 2.5% compared to 29.4% +/- 3.6%; 1 month, 36.4% +/- 2.6% versus 42.1% +/- 3.5%; 3 months, 36.5% +/- 3.0% vs. 45.5% +/- 2.2%; And 6 months, 37.2% +/- 3.4% versus 46.1% +/- 1.9% (p <0.001). The first patient performed at our center in Argentina in this series is alive and asymptomatic 15 years after implantation, and the rest of this series we do not have current data. A patient without visible vessels in the anterior wall of the left ventricle was treated with 18 hyperbaric chamber sections from one hour at 1.4 AT. After creating angiogenesis, the patient was operated on receiving 2 grafts (mammary and venous) without extracorporeal circulation in the anterior descending artery and diagonal artery. The preoperative ejection fraction was 33% at 90 months of follow up the ejection fraction was 58%. The patient at 90 months was asymptomatic. Of the idiopathic heart disease group, nine patients underwent median sternotomy, and received human fetal stem cells (HFDSCs from ectopic pregnancy or spontaneous abortion, three patients received autologous bone marrow stem cells ABMSC) and 1HFDSCs for Minimally Invasive Surgery.

Patients with HFDSC, compared to baseline, improved: The mean (±SD) NYHA class decreased from 3.4 ± 0.5 to 1.33 ± 0.5 (P = 0.001); Mean EF increased 31%, from 26.6% ± 4.0% to 34.8% ± 7.2% (p = 0.005); the yield in ETT increased 291.3%, from 4.25 minutes to 16.63 minutes (128.9% in metabolic equivalents, 2.45 to 5.63) (P <0.0001); the mean LVEDD decreased 15%, from 6.85 ± 0.6cm to 5.80 ± 0.58cm (P <0.001); the mean performance on the 6-minute walk test increased 43.2%, from 251 ± 113.1 seconds to 360 ± 0 seconds (P = 0.01); the mean distance increased 64.4%, from 284.4 ± 144.9m to 468.2 ± 89.8m (P = 0.004); and the mean score in the Minnesota congestive HF test decreased from 71 ± 27.3 to 6 ± 5.9 (p <0.001). Kaplan-Maier’s probability of survival at 40 months was 66%. No rejection or cancer was observed at follow-up, in this series follow-up was discontinued at 4 years. In idiopathic patients receiving autologous cells by Mininvasive technique preoperative NYHA was 3.6 (+/- 0.70) 6 months after receiving stem cell therapy. The mean value of the functional class was 1.9 (+/- 0.90) (p <0.005). ) showing marked clinical improvement. The preimplantation ejection fraction was 28% (+/- 3.6%) and at 6 months 44% (+/- 4.7%) (p <0.005). There was a similar change in ventricular diameters: After 6 months LVESV went from 50mm (+/- 3.3) to 42mm (+/- 4.5) (p <0.05). Two of the three patients in this group received re-synchronization therapy; one died at 10 years and 4 months, another at age 11 and another one alive at 12 years of the implant. More experience should be performed with different techniques and cells to find the appropriate treatment in this type of patients.

Read Full Article HTML DOI: 10.29328/journal.jsctt.1001010 Cite this Article Read Full Article PDF

Keywords:

Stem cells in patients with hear failure; Hyperbaric oxygen and angiogenesis in heart failure patients; Treatment of idiopathic myocadiopathy with stem cells; Autologous stem cells in patients with cardiac insuffi ciency; Embryophetal cells in patients with heart failure

References

  1. Remme WJ, Swedberg K. Task force for the diagnosis and treatment of chronic heart failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. European Heart Journal. 2001; 22: 1527-1560. Ref.: https://goo.gl/ENjTdx
  2. Colucci W, Braunwald E. Pathophysiology of Heart Failure, en Heart Disease de Braunwald. 5a Edition. 1997; 360-393.
  3. Enrique V, Carbajal MD, Prakas. Current Diagnosis and Treatment is Cardiology 2nd Ed. Congestive Heart Failure. 2003.
  4. Bolling SF, Pagani FD, Deeb GM. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg. 1998; 115: 381-386. Ref.: https://goo.gl/NiiBfR
  5. Wang JS, Shum D, Galipeau J. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg. 2000; 120: 999-1006. Ref.: https://goo.gl/1tNxfM
  6. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med. 2003; 9: 702-712. Ref.: https://goo.gl/8D8Qqc
  7. Orlic D, Kassutra J, Chimenti S, Jakoniuk I, Anderson SM, et al. Bone marrow cells regenerate infracted myocardium. Nature. 2001; 410: 701-705. Ref.: https://goo.gl/VDLjv3
  8. Edelberg JM, Tang L, Hattori K, Lyden D, Rafii S. Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circ Res. 2002; 90: E89-E93. Ref.: https://goo.gl/2dmhJe
  9. Shi Q, Rafi S, Wu MH, Wijelath ES, Yu C, et al. Evidence for circulating bone marrow-derived endothelial cells. Blood. 1998; 92: 362-367. Ref.: https://goo.gl/z2fWF3
  10. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 2002; 8: 403-409. Ref.: https://goo.gl/HnCjtL
  11. Otani A, Kinder K, Ewalt K, Otero FJ, Schimmel P, et al. Bone marrow derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat Med. 2002; 8: 1004-1010. Ref.: https://goo.gl/sJ98ME
  12. Young PP, Hofling AA, Sands MS. VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculalture of newborn murine recipients. Proc Natl Acad Sci USA. 2002; 99: 11951-11956. Ref.: https://goo.gl/TLhwpp
  13. Heyboer M, Milovanova TN, Wojcik S, Grant W, Chin M, et al. CD34+/CD45-dim stem cell mobilization by hyperbaric oxygen - changes with oxygen dosage. Stem Cell Res. 2014; 12: 638-645. Ref.: https://goo.gl/stqQak
  14. O´Donoghue K, Fisk NM. Fetal stem cells. Best Pract Res Clin Obstet Gynaecol. 2004; 18: 853-875. Ref.: https://goo.gl/WFgYr9
  15. Tsymbalyuk VI, Yaminsky YY. Usage of embryonic nerve tissue transplantation to improve the conductivity of spinal cord after traumatic damage in animals and humans. Transplantology. 2003; 4: 199-201.
  16. Zorin MO, Yurchenko TN, Latyshev DY. Application of cryopreserved suspension of embryonic neural cells in combined treatment of patients with ischemic insults of basal ganglias. Transplantology. 2003; 4:149-50.
  17. Salogub TV. Perspective of embryonic cell transplantation when treating patientswthepileptiform neuralgia of peripheric genesis. Transplantology. 2003; 4: 184-185. Ref.: https://goo.gl/BKqVuR
  18. Grischenko VI, Bobirova LE, DvornekIL,y col. Use of biotechnology in treatment of type I dabetes. Transplantology. 2003; 4:16-9.
  19. Benetti F, Penherrera E, Maldonado T, Vera YD, Subramanian V, et al. Direct Myocardial Implantation of Human Fetal Stem Cells in Heart Failure Patients: Long-term Results. Heart Surg Forum. 2010; 13: Ref.: https://goo.gl/FdnVfw
  20. Benetti F, Viña RF, Patel AN. OPCABG plus simultaneous autologus stem cells implants TCTMD.com. 2003.
  21. Patel AN, Geffner L, Vina RF, Saslavsky J, Kormos R, et al. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: A prospective randomized study: J Thorac Cardiovasc Surg. 2005; 130: 1631-1638. Ref.: https://goo.gl/XTr3sq
  22. Meerson FZ. The myocardium in hyperfunction, hypertrophy and heart failure. Circ Res. 1969; 25: 1-163 Ref.: https://goo.gl/ebUrEX
  23. Zak R. Cardiac hipertrophy: biochemical and cellular relationships. Hosp Pract. 2016; 18: 85-97. Ref.: https://goo.gl/3rKRxD
  24. Prosper F, Pérez A, Merino J. Adult stem cells for myocardial repair. Basic ApplMyol 13(1):15-22,2003.
  25. Colucci WS, Braunwald E. Patophisiology of heart failure in Braunwald¨s Heart Disease 5th edition Saunders company 1997.
  26. Prockop DJ. Marrow Stromal cells as Stem Cells for nonhematopoietic tissues. Science. 1997; 276: 71-74 Ref.: https://goo.gl/m4UcND
  27. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284: 143-147. Ref.: https://goo.gl/UcXFMi
  28. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, et al. Cardiomyocites can be generated from marrow stromal cells in vitro. J Clin Invest. 1999; 103: 697-705. Ref.: https://goo.gl/N4GYGu
  29. Xu M, Wani M, Dai YS, Wang J, Yan M, et al. Differentiation of bone marrow stromal cells into cardiac phenotype requires intracellular communication with myocites. Circulation 2004; 110: 2658-2665. Ref.: https://goo.gl/kQKnXu
  30. Chedrawy EG, Wang JS, Nguyen DM, Shum-Tim D, Chiu R. Incorporation and integration of implanted myogenic and stem cells into native myocardial fibres: anatomic basis for functional improvements. J Thorac Cardiovasc Surg. 2002; 124: 584-590 Ref.: https://goo.gl/wnW8fH
  31. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circulation research. 2004; 95: 9-20 Ref.: https://goo.gl/MQHvLH
  32. Vilas-Boas F, Feitosa GS, Soares MB, Pinho-Filho JA, Mota A, et al. Bone marrow cell transplantation to the myocardium of a patient with heart failure due to Chagas disease. Arg Bras Cardiol. 2004; 82: 181-184. Ref.: https://goo.gl/72WixZ

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Figure 1

Figure 3

Figure 1

Figure 4

Figure 1

Figure 5

Figure 1

Figure 6

Figure 1

Figure 7

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More